Bellerophon Therapeutics, Inc.

LSE:0HMP Stock Report

Market Cap: US$440.4k

Bellerophon Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

LSE:0HMP Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
13 Oct 23SellUS$111,776Puissance Capital Management LPCompany1,076,841US$0.10

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 0HMP?
Owner TypeNumber of SharesOwnership Percentage
Institutions4,5170.0369%
Individual Insiders1,002,6508.2%
Hedge Funds1,026,8688.39%
General Public10,198,61383.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 12 shareholders own 16.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.39%
Lepercq de Neuflize Asset Management LLC
1,026,868US$37.0k0%100.0%
5.26%
Michael Nelson
642,844US$23.1k0%no data
1.61%
Naseem Amin
196,670US$7.1k0%no data
0.5%
Theodore Wang
60,913US$2.2k0%no data
0.28%
Peter Fernandes
34,649US$1.2k0%no data
0.21%
Martin Dekker
25,973US$935.00%no data
0.2%
Parag Shah
24,705US$889.40%no data
0.1%
Nicholas Laccona
12,470US$448.90%no data
0.037%
Dimensional Fund Advisors LP
4,517US$162.60%no data
0.014%
Bobae Kim
1,723US$62.00%no data
0.012%
Mary Cloyd
1,457US$52.40%no data
0.01%
Scott Bruder
1,246US$44.90%no data